Table 1.
In- and exclusion criteria.
Fig 1.
Flow diagram of participants enrolled and analyzed in this study.
Table 2.
Participant characteristics.
Table 3.
Reported adverse events out of 36 HCQ administrations by inhalation in 12 participants.
Table 4.
Change in FEV1 post inhalation compared to baseline in %: Mean and range.
Table 5.
QTc time at baseline and 3,5 hours after inhalation.